1022152-70-0
Chemical Structure
MK-5046
- CAS No.: 1022152-70-0
- Formula:C20H18F6N4O
- Molecular Weight:444.37
IUPAC Name: (S)-2-(4-(1H-pyrazol-1-yl)phenyl)-1,1,1-trifluoro-3-(4-((1-(trifluoromethyl)cyclopropyl)methyl)-1H-imidazol-2-yl)propan-2-ol
InChIKey: UJINBEQCDMOAHM-SFHVURJKSA-N
SMILES: O[C@](CC1=NC(CC2(C(F)(F)F)CC2)=CN1)(C(F)(F)F)C3=CC=C(N4C=CC=N4)C=C3
Biological Activity: MK-5046 is a potent, selective and orally active Bombesin receptor subtype-3 (BRS-3) allosteric agonist with an IC50 and an EC50 value of 27 and 25 nM for hBRS-3, respectively. MK-5046 inhibits food intake and reduces body weight of diet-induced obese (DIO) mouse models. MK-5046 can be used for the research of obesity[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MK-5046 | 99.75% | MK-5046 is a potent, selective and orally active Bombesin receptor subtype-3 (BRS-3) allosteric agonist with an IC50 and an EC50 value of 27 and 25 nM for hBRS-3, respectively. MK-5046 inhibits food intake and reduces body weight of diet-induced obese (DIO) mouse models. MK-5046 can be used for the research of obesity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 1.00
HY-14342A(R)-MK-5046 -
Similarity Score 0.45
HY-179648CD28-IN-2 -
Similarity Score 0.42
HY-111512PF-06795071 -
Similarity Score 0.42
HY-150641CDK-IN-9 -
Similarity Score 0.42
HY-W0805632,2-Bis(4-carboxyphenyl)hexafluoropropane -
Similarity Score 0.42
HY-W654078Bisphenol AF-13C12 -
Similarity Score 0.41
HY-14234Glucocorticoid receptor agonist -
Similarity Score 0.41
HY-U00254L791943 -
Similarity Score 0.41
HY-117558(Rac)-L-826141 -
Explore the MedChemAI to find more analogs
References
- [1]. Guan XM, et al. Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist. J Pharmacol Exp Ther. 2011 Feb;336(2):356-364. [Content Brief]
- [2]. Sebhat IK, et al. Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity. ACS Med Chem Lett. 2010 Oct 18;2(1):43-47. [Content Brief]
- [3]. Ramos-Alvarez I, et al. The Nonpeptide Agonist MK-5046 Functions As an Allosteric Agonist for the Bombesin Receptor Subtype-3. J Pharmacol Exp Ther. 2022 Aug;382(2):66-78. [Content Brief]
